LetterExperts have warned that warning to most people in the UK is “very important” for most people in the UK, but experts have warned that it is not enough to deal with the crisis alone.
Nasta’s leading social think tank says that if the UK wants to reduce obesity, most drugs are required in the NHS.
But its analysis has said that Jabs is not the only solution – and that a mass collection can leave taxpayers with a “massive bills” in 5 years.
Instead, the government should bring weight loss JABs to a group of selected people, while creating a series of policies to counter other stimulants for obesity, such as selling high salt and high sugar foods.
Nasta said the right combination approach can halve obesity in the UK in five years.
“Half obesity is possible in the next five years, and weight loss drugs are an important part of how to get it,” said Hugo Harper, a healthy life director in Nasta. Independent
“But relying on weight loss drugs alone to reduce the rate of obesity, it needs a large bill to remove taxpayers.”
Nasta’s unique analysis, shared IndependentIt shows that the cost of £ 500m a year for Jabs for people in need-about 150,000 people-is the most cost-effective way to approach this.
This, in combination with other measures, such as banning prices in some foods, can reduce the cost of obesity by about £ 53 billion a year.
New figures reported by Independent Last month, it showed that the cost of the British Balloon Obesity Crisis rose to £ 107 billion each year. Coping with obesity was recognized as an important area of politics in the 10 -year NHS program because health services appear to reduce costs to fill in a fraction of 6.6 billion pounds.
“Our modeling shows that more people need GLP-1 drugs to change our current redirection,” Mr Harper said.
“[But] Instead, an approach that distributes weight loss drugs for the treatment of people in need will be more effective and economical, while also taking strong preventive measures-such as mandatory health goals for the largest retailers and more strict advertising restrictions on junk food. ”
Nasta’s analysis consists of only the costs of samglytide, which is active in Wegovy, not the Tirzepatide, found in Jab Mount and the focus of NHS Rollut, which began early this year.
More than one in four adults live with obesity – a level that has doubled since the 1990s. A weak or over -diet, along with inactivity, genetics, specific medications and hygiene such as hypothyroidism, is the main cause of obesity that can slow down the metabolism.
The current NHS program aims to reach 220,000 in the next three years, as part of a 12 -year program.
Mr Harper said obesity is in the “root” of British health challenges, such as cancer and diabetes, adding: “We cannot lower the cans to deal with obesity.”
“This is only worse without intervention, because the rate of obesity increases,” he said.
While the expansion of weight loss JABs can save tens of billions of dollars, the obesity alliance agrees that the use of treatment without dealing with the “food environment”-such as promoting unhealthy foods in supermarkets-a “imagination”.
Alfred Slade, the leadership of government affairs in alliance, said Independent: “Providing the idea that we only take two -thirds of the crowd forever is a perfect imagination, and we think it is ridiculous that we have come to the scene where people feel comfortable.
“I think the general public has been sold with the idea that this is a miracle. They are a tool. They lead to great health progress.
“But unless we do something to make it easier for people by removing the food environment where people live, so it is a lot of money for many people to spend.”
The NHS app is not enough
Under the current NHS scheme for Jabs weight loss, 220,000 patients will be able to access Jabs in the next 12 years. However, current estimates show that at least 3.4 million patients can qualify.
Speaking exclusively with Independently The Giant Eli Lily, who supplies King Kong of the weight loss front, has warned that the NHS Rollyt does not go quickly or wide enough to fix the problem.
Professor Rachel Batnam, Vice President of Medical International Affairs, said: “In any area, another disease that leads to premature death, we do not want to say 12 years.
According to Ms. Butneham, the current scale of rotation means that only 11 people in each general practitioner can access the treatment.
He said the prevalence of obesity has increased by 10 % over the past decade, so “whatever we do or we have done now does not work.”
“We need prevention to prevent overweight and obesity, and then all of its complications, but then we also need treatment for people who have pre -obesity,” he said.
Weight loss displacements do not work alone
Current research suggests that the overwhelming majority of people who start the treatment of JAB weight loss decides not to use the drugs indefinitely. When they stop using Jabs, almost all gain about 100 % of weight.
Ms. Battram said The “sacred grill” for weight loss movements is to reach a stage where a patient can regulate his or her weight, not to live in them. However, he admitted that the investigation was “a long way from it”.
“We support more access to all forms of effective obesity, including drugs, but many other things that we think are a bit of little value with all the focus on drugs,” said Slade.
“The essential driver of rising obesity has been the commercial food environment … it is more profitable for companies to sell food that is worse for our health.”
Currently, barium surgery is the only obesity treatment that has evidence of long -term results.
Mr Ahmad Ahmad, head of the British Metabolic Obesity and Surgery Association, said the United Kingdom is failing to access obesity surgery because it is “chronic shortage”.
Patients have been waiting for surgery for two to three years, but the NHS can have enough surgeons and theaters to increase barium surgery from 5,000 to 20,000 a year, “he said.
Dr. Adrian Htter, general practitioner and medical director of clinical policy at the Royal College of GPS, said targeting people’s environments as a way to prevent obesity has been largely overlooked.
“We haven’t had this very serious conversation with our patients, that is,: Yes, you can have these technologies. However, you are at risk in your surroundings and food is one of these risks,” he said.
“This is a broader issue. This is actually about nutrition, not obesity. I think people and sometimes politicians sometimes don’t necessarily think about it.”
A spokesman for the Ministry of Health and Social Care said obesity is now one of the main reasons for health and that weight loss JABs can be one of the ways to deal with “obesity epidemic.”
“This government is determined to bring modern modern therapies to everyone they need, not just those who are capable of paying for it,” he said.
